Regado Biosciences (RGDO) Misses Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts RGDO Hot Sheet
Join SI Premium – FREE
Regado Biosciences (NASDAQ: RGDO) reported Q2 EPS of ($0.63), $0.12 worse than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Regado Biosciences (RGDO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX's spectrum deal puts SIRI's satellite assets in focus
- Community Healthcare Trust (CHCT) PT Lowered to $17 at Truist Securities
- UBS Reiterates Buy Rating on EMCOR Group (EME) Into Q3 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
